[{"address1": "680 East Colorado Boulevard", "address2": "Suite 180", "city": "Pasadena", "state": "CA", "zip": "91101", "country": "United States", "phone": "631 830 7092", "fax": "631 982 5050", "website": "https://lixte.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Lixte Biotechnology Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies. Its lead product candidate, LB-100 is in phase 1b clinical trials combined with Atezolizumab for patients with microsatellite stable metastatic colorectal cancer. The company's LB-100 combined with doxorubicin in advanced soft tissue sarcoma is under Phase 1b portion; and LB-100 combined with dostarlimab that is in phase 1b/2 for ovarian clear cell carcinoma. The company has a clinical trial research agreement with the Netherlands Cancer Institute; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group; and a development collaboration agreement with the Netherlands Cancer Institute. Lixte Biotechnology Holdings, Inc. was founded in 2005 and is based in Pasadena, California.", "fullTimeEmployees": 2, "companyOfficers": [{"maxAge": 1, "name": "Mr. Bastiaan  van der Baan M.Sc.", "age": 52, "title": "President, CEO & Chairman of the Board of Directors", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 172784, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert Neal Weingarten", "age": 72, "title": "CFO, VP & Secretary", "yearBorn": 1952, "fiscalYear": 2023, "totalPay": 175000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Johannes Henricus Matthias Schellens M.D., Ph.D.", "age": 67, "title": "Consultant & Chief Medical Officer", "yearBorn": 1957, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.39, "open": 1.355, "dayLow": 1.315, "dayHigh": 1.355, "regularMarketPreviousClose": 1.39, "regularMarketOpen": 1.355, "regularMarketDayLow": 1.315, "regularMarketDayHigh": 1.355, "payoutRatio": 0.0, "beta": 0.368, "volume": 3157, "regularMarketVolume": 3157, "averageVolume": 19577, "averageVolume10days": 19340, "averageDailyVolume10Day": 19340, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 3569276, "fiftyTwoWeekLow": 1.02, "fiftyTwoWeekHigh": 3.5, "fiftyDayAverage": 1.2658, "twoHundredDayAverage": 1.7153, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 5684584, "profitMargins": 0.0, "floatShares": 2523701, "sharesOutstanding": 2684070, "sharesShort": 32595, "sharesShortPriorMonth": 26526, "sharesShortPreviousMonthDate": 1744675200, "dateShortInterest": 1747267200, "sharesPercentSharesOut": 0.0121, "heldPercentInsiders": 0.18431999, "heldPercentInstitutions": 0.15843001, "shortRatio": 2.07, "shortPercentOfFloat": 0.0123000005, "impliedSharesOutstanding": 2684070, "bookValue": -0.872, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -3324198, "trailingEps": -1.45, "lastSplitFactor": "1:10", "lastSplitDate": 1685923200, "52WeekChange": -0.45041323, "SandP52WeekChange": 0.119305134, "quoteType": "EQUITY", "currentPrice": 1.3298, "recommendationKey": "none", "totalCash": 1384697, "totalCashPerShare": 0.516, "totalDebt": 0, "quickRatio": 3.899, "currentRatio": 4.264, "returnOnAssets": -0.81143, "returnOnEquity": -1.5513699, "freeCashflow": -1725609, "operatingCashflow": -2943794, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "LIXT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "priceToBook": -1.5250001, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "postMarketTime": 1749251709, "regularMarketTime": 1749240000, "exchange": "NCM", "messageBoardId": "finmb_29181356", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Lixte Biotechnology Holdings, I", "marketState": "CLOSED", "longName": "Lixte Biotechnology Holdings, Inc.", "corporateActions": [], "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1193319000000, "postMarketChangePercent": 0.759513, "postMarketPrice": 1.3399, "postMarketChange": 0.0101, "regularMarketChange": -0.060199976, "regularMarketDayRange": "1.315 - 1.355", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 19577, "fiftyTwoWeekLowChange": 0.30980003, "fiftyTwoWeekLowChangePercent": 0.3037255, "fiftyTwoWeekRange": "1.02 - 3.5", "fiftyTwoWeekHighChange": -2.1701999, "fiftyTwoWeekHighChangePercent": -0.6200571, "fiftyTwoWeekChangePercent": -45.04132, "dividendDate": 1605830400, "earningsTimestamp": 1747053000, "earningsTimestampStart": 1754510400, "earningsTimestampEnd": 1754942400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.45, "fiftyDayAverageChange": 0.06400001, "fiftyDayAverageChangePercent": 0.050560918, "twoHundredDayAverageChange": -0.38549995, "twoHundredDayAverageChangePercent": -0.22474201, "regularMarketChangePercent": -4.3309336, "regularMarketPrice": 1.3298, "displayName": "Lixte Biotechnology", "trailingPegRatio": null, "__fetch_time": "2025-06-07"}]